SAB5600227
抗-His-Tag抗体，兔单克隆
recombinant, expressed in HEK 293 cells, clone RM146, purified immunoglobulin
别名:
10 His表位标签, 6 His表位标签, HHHHHH 标签, 多组氨酸标签
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
NACRES:
NA.41
UNSPSC Code:
12352203
Clone:
RM146, monoclonal, recombinant monoclonal
Species reactivity:
all
Application:
FACS, ICC, IHC, IP, WB
Citations:
6
recombinant
expressed in HEK 293 cells
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
RM146, monoclonal, recombinant monoclonal
form
buffered aqueous glycerol solution
species reactivity
all
technique(s)
flow cytometry: 0.5-2 μg/mL, immunocytochemistry: 0.5-2 μg/mL, immunohistochemistry: 0.1—1 μg/mL, immunoprecipitation (IP): 0.5-2 μg/mL, western blot: 0.1— 1 μg/mL
isotype
IgG
NCBI accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Immunogen
在N端带有6xHis标签的肽与在C端带有6xHis标签的另一种肽的混合物。
Biochem/physiol Actions
该抗体与含有融合到氨基或羧基末端的6xHis标签或10xHis标签的重组蛋白反应。与哺乳动物或细菌细胞中的其他内源性蛋白质无交叉反应性。
Physical form
溶于含有50％甘油/PBS、1％BSA和0.09％叠氮化钠的磷酸盐缓冲液中。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Still not finding the right product?
试用我们的 产品选型工具 工具缩小选择范围
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
低风险生物材料
常规特殊物品
此项目有
Tarah Elizabeth Trebino et al.
eLife, 12 (2023-12-27)
BRAF is a key member in the MAPK signaling pathway essential for cell growth, proliferation, and differentiation. Mutant BRAF is often the underlying cause of various types of cancer and mutant RAS, the upstream regulator of BRAF, is a driver
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.
Minenkova, et al.
Molecular Therapy, 30, 1979-1993 (2022)
Harman Malhi et al.
Cell reports. Medicine, 3(6), 100658-100658 (2022-06-16)
Epstein-Barr virus (EBV) is a cancer-associated pathogen responsible for 165,000 deaths annually. EBV is also the etiological agent of infectious mononucleosis and is linked to multiple sclerosis and rheumatoid arthritis. Thus, an EBV vaccine would have a significant global health